[ad_1] Shares of Dr. Reddy’s Laboratories Ltd. declined over 5% during Friday’s early trading session after the company announced its December quarter results. The Q3 earnings revealed subdued numbers and margins, reflecting the impact of heightened competition in the generics segment. Company Value Change %Change The drugmaker reported EBITDA margin of 27.5% for the quarter, […]